MGTA Annual Operating Expenses
$80.90 M
+$6.21 M+8.31%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual total operating expenses is $80.90 million, with the most recent change of +$6.21 million (+8.31%) on December 31, 2022. During the last 3 years, it has fallen by -$2.07 million (-2.49%).MGTA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Operating Expenses
$5.46 M
-$8.67 M-61.37%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly total operating expenses is $5.46 million, with the most recent change of -$8.67 million (-61.37%) on June 30, 2023. Over the past year, it has dropped by -$12.63 million (-69.82%).MGTA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.3% | -69.8% |
3 y3 years | -2.5% | -72.7% |
5 y5 years | +126.4% | -61.1% |
MGTA Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -2.5% | -77.9% |
Magenta Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $5.46 M(-61.4%) |
Mar 2023 | - | $14.13 M(-35.0%) |
Dec 2022 | $80.90 M(+8.3%) | $21.73 M(+26.0%) |
Sept 2022 | - | $17.25 M(-4.6%) |
June 2022 | - | $18.08 M(-24.1%) |
Mar 2022 | - | $23.83 M(+18.3%) |
Dec 2021 | $74.69 M(-5.1%) | $20.14 M(+10.4%) |
Sept 2021 | - | $18.25 M(+3.6%) |
June 2021 | - | $17.61 M(-5.8%) |
Mar 2021 | - | $18.70 M(-1.9%) |
Dec 2020 | $78.70 M | $19.07 M(+3.7%) |
Sept 2020 | - | $18.38 M(-8.2%) |
June 2020 | - | $20.01 M(-5.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | $21.24 M(-13.8%) |
Dec 2019 | $82.97 M(+38.4%) | $24.64 M(+8.8%) |
Sept 2019 | - | $22.64 M(+17.1%) |
June 2019 | - | $19.34 M(+18.3%) |
Mar 2019 | - | $16.35 M(-8.8%) |
Dec 2018 | $59.96 M(+67.8%) | $17.93 M(+7.4%) |
Sept 2018 | - | $16.70 M(+19.1%) |
June 2018 | - | $14.03 M(+24.0%) |
Mar 2018 | - | $11.31 M(+38.4%) |
Dec 2017 | $35.73 M(+285.5%) | $8.17 M(+16.5%) |
Sept 2017 | - | $7.01 M(-55.4%) |
June 2017 | - | $15.73 M(+227.0%) |
Mar 2017 | - | $4.81 M |
Dec 2016 | $9.27 M | - |
FAQ
- What is Magenta Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Magenta Therapeutics?
- What is Magenta Therapeutics annual operating expenses year-on-year change?
- What is Magenta Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly operating expenses year-on-year change?
What is Magenta Therapeutics annual total operating expenses?
The current annual operating expenses of MGTA is $80.90 M
What is the all time high annual operating expenses for Magenta Therapeutics?
Magenta Therapeutics all-time high annual total operating expenses is $82.97 M
What is Magenta Therapeutics annual operating expenses year-on-year change?
Over the past year, MGTA annual total operating expenses has changed by +$6.21 M (+8.31%)
What is Magenta Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of MGTA is $5.46 M
What is the all time high quarterly operating expenses for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly total operating expenses is $24.64 M
What is Magenta Therapeutics quarterly operating expenses year-on-year change?
Over the past year, MGTA quarterly total operating expenses has changed by -$12.63 M (-69.82%)